“By the age of 80, one in three people develops Alzheimer’s. I’m trying to move the curve to 85 or 90 or maybe beyond.”
A novel Alzheimer’s disease treatment now in advanced Phase 3 clinical trials could also prove effective in treating lung inflammation caused by Covid-19.